| 2022-05-06 | -35.8% | legal | SEC EDGAR | GH 8-K: 5.02 (SEC Filing) |
| 2025-10-29 | +33.9% | earnings | Seeking Alpha | Guardant Health Non-GAAP EPS of -$0.39 beats by $0.10, revenue of $265.2M beats by $29.51M |
| 2025-10-29 | +33.9% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2025-10-29 | +33.9% | earnings | Yahoo Finance | Guardant Health (GH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance |
| 2025-10-29 | +33.9% | earnings | TradingView | Guardant Health’s (NASDAQ:GH) Q3: Strong Sales, Stock Jumps 15.5% - TradingView |
| 2025-10-29 | +33.9% | earnings | Quiver Quantitative | GUARDANT HEALTH Earnings Results: $GH Reports Quarterly Earnings - Quiver Quantitative |
| 2025-10-30 | +29.5% | earnings | Seeking Alpha | Guardant Health jumps after beating Q3 estimates and increasing FY outlook |
| 2025-10-30 | +29.5% | earnings | Seeking Alpha | Guardant Health, Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-10-30 | +29.5% | earnings | Seeking Alpha | Guardant Health raises 2025 revenue outlook to $970M with Shield partnerships and strong oncology growth |
| 2025-10-30 | +29.5% | earnings | Seeking Alpha | Guardant Health, Inc. (GH) Q3 2025 Earnings Call Transcript |
| 2025-10-30 | +29.5% | news | The Motley Fool | Why Guardant Health Stock Surged Today - The Motley Fool |
| 2025-10-30 | +29.5% | news | Seeking Alpha | Guardant Health Stock: Business Continues To Gather Pace (NASDAQ:GH) - Seeking Alpha |
| 2025-10-30 | +29.5% | news | StocksToTrade | Guardant Health’s Surprise Surge: Here’s Why - StocksToTrade |
| 2022-05-05 | -25.9% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2024-05-09 | +19.3% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2024-11-06 | +18.3% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2023-05-09 | +17.1% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2024-02-22 | -16.4% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2026-04-09 | -15.8% | news | GuruFocus | Guardant Health Inc (GH) Stock Price Down 4.62% on Apr 9 - GuruFocus |
| 2026-04-09 | -15.8% | earnings | MarketBeat | Aberdeen Group plc Sells 40,577 Shares of Guardant Health, Inc. $GH - MarketBeat |
| 2024-05-24 | +15.5% | legal | SEC EDGAR | GH 8-K: 8.01 and (SEC Filing) |
| 2023-12-21 | +12.8% | legal | SEC EDGAR | GH 8-K: 1.01, 8.01 (SEC Filing) |
| 2023-01-09 | +11.6% | legal | SEC EDGAR | GH 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-20 | -10.9% | M&A | Seeking Alpha | Guardant Health acquires Israeli healthtech MetaSight for up to $150M |
| 2026-02-20 | -10.9% | earnings | Seeking Alpha | Guardant Health outlines 27%–30% revenue growth for 2026 while expanding Shield and oncology portfolio |
| 2026-02-20 | -10.9% | earnings | Seeking Alpha | Guardant Health, Inc. (GH) Q4 2025 Earnings Call Transcript |
| 2024-07-29 | +10.4% | legal | SEC EDGAR | GH 8-K: 8.01 and (SEC Filing) |
| 2025-02-20 | -10.4% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2026-04-08 | -9.7% | executive | TMX Newsfile | OS Therapies Appoints Craig Eagle, MD as Strategic Advisor |
| 2023-11-15 | -9.0% | legal | SEC EDGAR | GH 8-K: 8.01 and (SEC Filing) |
| 2023-11-06 | -9.0% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2025-11-21 | +8.4% | news | Seeking Alpha | LLY joins $1T club but doesn't feature in SA's top 10 large-cap healthcare stocks |
| 2025-09-04 | -8.1% | news | Yahoo Finance | Why Guardant Health (GH) Shares Are Plunging Today - Yahoo Finance |
| 2026-01-06 | +7.6% | news | Investing.com | Guardant Health stock hits 52-week high at 112.43 USD - Investing.com |
| 2024-08-07 | -7.5% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2026-02-23 | -7.2% | news | TradingView | Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know - TradingView |
| 2023-02-27 | +7.0% | legal | SEC EDGAR | GH 8-K: 5.02 and (SEC Filing) |
| 2022-07-07 | +6.9% | legal | SEC EDGAR | GH 8-K: 5.02 and (SEC Filing) |
| 2026-03-30 | +6.6% | legal | CNW Group | Canadian Investment Regulatory Organization Trade Resumption - GH |
| 2026-03-30 | +6.6% | news | Business Wire | Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan |
| 2026-03-30 | +6.6% | news | Stock Titan | Japan clears ENHERTU for hard-to-treat HER2 tumors with AI-backed data - Stock Titan |
| 2026-04-10 | -6.6% | earnings | MarketBeat | Guardant Health (NASDAQ:GH) Shares Down 7% - Time to Sell? - MarketBeat |
| 2023-12-19 | -6.6% | legal | SEC EDGAR | GH 8-K: 8.01 and (SEC Filing) |
| 2025-10-31 | +6.5% | earnings | Seeking Alpha | Guardant Health Beats Expectations: Shield, Quest, And AI Catalysts |
| 2025-10-31 | +6.5% | news | Seeking Alpha | Guardant Health: Business Continues To Gather Pace |
| 2025-10-31 | +6.5% | earnings | Yahoo Finance | Guardant Health (GH) Jumps to New Record High on Earnings Blowout, Bullish Outlook - Yahoo Finance |
| 2025-10-31 | +6.5% | news | simplywall.st | Guardant Health, Inc. (NASDAQ:GH) Stocks Shoot Up 48% But Its P/S Still Looks Reasonable - simplywall.st |
| 2025-11-20 | +6.4% | news | Investing.com | Guardant Health director Tariq Musa sells $11,165 in stock - Investing.com |
| 2025-07-31 | -6.3% | earnings | Yahoo Finance | Guardant Health Inc (GH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Raised ... - Yahoo Finance |
| 2022-02-23 | +6.3% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2025-11-02 | +6.2% | earnings | simplywall.st | Earnings Update: Guardant Health, Inc. (NASDAQ:GH) Just Reported And Analysts Are Boosting Their Estimates - simplywall.st |
| 2023-08-01 | -5.7% | legal | SEC EDGAR | GH 8-K: 8.01 and (SEC Filing) |
| 2026-03-11 | -5.5% | news | Seeking Alpha | Guardant Health, Inc. (GH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript |
| 2026-02-27 | -5.4% | news | Yahoo Finance | Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance |
| 2023-08-03 | +5.4% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2026-04-16 | +5.0% | news | Business Wire | Guardant Health to Report First Quarter 2026 Financial Results on May 7, 2026 |
| 2026-04-16 | +5.0% | earnings | Stock Titan | After market close May 7, Guardant Health will webcast Q1 results - Stock Titan |
| 2026-04-16 | +5.0% | news | Stock Titan | Guardant Health (GH) director sells 116 shares after RSU conversion - Stock Titan |
| 2026-04-16 | +5.0% | news | simplywall.st | Guardant Health (GH) Valuation Check After Short Term Share Price Volatility - simplywall.st |
| 2026-04-16 | +5.0% | earnings | MarketBeat | Guardant Health, Inc. $GH Position Cut by Massachusetts Financial Services Co. MA - MarketBeat |
| 2026-04-16 | +5.0% | news | Stock Titan | 9,840-share Form 144 sale by Guardant Health (NASDAQ: GH) - Stock Titan |
| 2026-04-16 | +5.0% | news | Investing.com | Tariq Musa, Guardant Health director, sells $9840 in stock - Investing.com |
| 2026-04-16 | +5.0% | news | Stock Titan | Guardant Health (GH) CLO RSUs Vest with Shares Withheld for Tax Obligations - Stock Titan |
| 2025-10-27 | -5.0% | news | Seeking Alpha | Guardant Health, Zephyr AI partner to find biomarkers for targeted cancer treatments |
| 2023-02-23 | +5.0% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2026-04-05 | -4.9% | earnings | MarketBeat | Guardant Health, Inc. (NASDAQ:GH) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat |
| 2026-04-04 | -4.9% | news | Simply Wall St. | Guardant Health (GH) Valuation Check After Strong 1 Year Return And Recent 90 Day Pullback |
| 2025-07-30 | -4.9% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2024-08-23 | -4.9% | legal | SEC EDGAR | GH 8-K: 1.01 and (SEC Filing) |
| 2025-11-25 | -4.7% | news | Yahoo Finance | Guardant Health (GH): Valuation in Focus After Obamacare Subsidy Extension Proposal Spurs Stock Surge - Yahoo Finance |
| 2026-01-16 | +4.7% | news | Investing.com | Guardant Health stock hits 52-week high at 113.98 USD - Investing.com |
| 2021-05-06 | -4.6% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2021-11-04 | -4.6% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2026-02-19 | -4.5% | earnings | Seeking Alpha | Guardant Health Non-GAAP EPS of -$0.50 misses by $0.03, revenue of $281.3M beats by $9.02M |
| 2026-02-19 | -4.5% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2026-02-19 | -4.5% | earnings | Yahoo Finance | Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance |
| 2026-02-19 | -4.5% | earnings | Yahoo Finance | Compared to Estimates, Guardant Health (GH) Q4 Earnings: A Look at Key Metrics - Yahoo Finance |
| 2026-02-19 | -4.5% | earnings | TradingView | Guardant Health (NASDAQ:GH) Surprises With Q4 CY2025 Sales - TradingView |
| 2026-01-19 | +4.5% | M&A | Stock Titan | New Guardant–Merck deal backs approval of future cancer drugs - Stock Titan |
| 2026-01-18 | +4.5% | news | Seeking Alpha | Guardant Health: Shield Colorectal Cancer Screening To Sustain Growth |
| 2026-01-20 | +4.1% | analyst | Yahoo Finance | Analysts Turn More Bullish on Guardant Health, Inc. (GH) as 2026 Growth Catalysts Build - Yahoo Finance |
| 2024-07-18 | -4.1% | legal | SEC EDGAR | GH 8-K: 5.02 and (SEC Filing) |
| 2025-11-23 | +4.1% | earnings | TradingView | Guardant Health (GH): Buy, Sell, or Hold Post Q3 Earnings? - TradingView |
| 2025-12-03 | +4.1% | executive | Investing.com | Guardant Health (GH) chief people officer sells $5.8m in stock - Investing.com |
| 2025-12-03 | +4.1% | news | Finviz | Why Guardant Health (GH) Stock Is Up Today - Finviz |
| 2023-05-25 | -4.0% | legal | SEC EDGAR | GH 8-K: 8.01 and (SEC Filing) |
| 2025-12-04 | -4.0% | news | Yahoo Finance | Is Guardant Health (GH) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance |
| 2026-03-20 | -4.0% | expansion | Yahoo Finance | Guardant Health (GH) Partners With Manulife to Launch Shield Multi-Cancer Detection Test in Asia - Yahoo Finance |
| 2026-01-30 | +3.8% | news | The Motley Fool | Should You Buy Guardant Health Before Feb. 19? - The Motley Fool |
| 2025-10-14 | +3.7% | earnings | Seeking Alpha | Guardant Health: Hold Rating Ahead Of Q3 Results On Valuation And Execution Risk |
| 2021-10-20 | +3.6% | legal | SEC EDGAR | GH 8-K: 5.02 and (SEC Filing) |
| 2021-05-17 | +3.5% | legal | SEC EDGAR | GH 8-K: 8.01 (SEC Filing) |
| 2025-02-07 | -3.4% | legal | SEC EDGAR | GH 8-K: 1.01, 3.02 (SEC Filing) |
| 2025-09-29 | +3.4% | legal | Seeking Alpha | Guardant Health gets FDA nod for Guardant360 CDx as a companion diagnostic |
| 2025-09-29 | +3.4% | news | Yahoo Finance | Why Guardant Health (GH) Stock Is Trading Up Today - Yahoo Finance |
| 2026-04-22 | -3.4% | news | Stock Titan | Guardant Health (GH) director Mignone gains 264 shares through RSU vesting - Stock Titan |
| 2026-03-10 | -3.2% | news | Investing.com | Hidalgo Medina sells Guardant Health (GH) shares for $118,996 - Investing.com |
| 2025-11-04 | -3.1% | news | Seeking Alpha | Guardant Health announces proposed $300 million offering of convertible senior notes due 2033 |
| 2025-11-04 | -3.1% | news | Yahoo Finance | Guardant Health Announces Proposed Public Offering of Common Stock - Yahoo Finance |
| 2026-01-12 | -2.9% | earnings | Seeking Alpha | Guardant Health guides Q4 and FY25 revenue above consensus |
| 2026-01-12 | -2.9% | legal | SEC EDGAR | GH 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-01-07 | +2.9% | legal | SEC EDGAR | GH 8-K: 8.01 and (SEC Filing) |
| 2022-11-03 | +2.9% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2026-01-23 | -2.7% | news | Yahoo Finance | Wall Street Has a Positive Opinion on Guardant Health (GH) - Yahoo Finance |
| 2026-03-16 | +2.5% | news | Seeking Alpha | Most oversold healthcare stocks above $10B on Wall Street amid Middle East disruptions |
| 2026-03-16 | +2.5% | news | Stock Titan | Blood test that screens for 10 cancers to reach Manulife customers in Asia - Stock Titan |
| 2026-01-10 | -2.5% | news | Yahoo Finance | Is Guardant Health (GH) Share Surge Justified By Recent Valuation Signals? - Yahoo Finance |
| 2026-01-10 | -2.5% | analyst | Yahoo Finance | Guggenheim Analyst is Bullish on Guardant Health, Inc. (GH) - Yahoo Finance |
| 2025-02-14 | +2.5% | legal | SEC EDGAR | GH 8-K: 1.01, 2.03, 3.02 (SEC Filing) |
| 2025-10-17 | +2.4% | news | Yahoo Finance | A Fresh Look at Guardant Health (GH) Valuation Following Recent Share Price Rally - Yahoo Finance |
| 2026-02-25 | +2.4% | earnings | Seeking Alpha | Guardant Health, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2025-12-06 | +2.4% | earnings | Yahoo Finance | Why Guardant Health (GH) Is Down 5.9% After Big Q3 Beat And Major Capital Raise – And What's Next - Yahoo Finance |
| 2025-04-09 | -2.3% | legal | SEC EDGAR | GH 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-04-02 | -2.2% | news | StockStory | 1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds |
| 2026-04-02 | -2.2% | executive | Stock Titan | Guardant Health (GH) CFO exercises 12,777 RSUs; 6,869 shares withheld for taxes - Stock Titan |
| 2026-04-02 | -2.2% | news | Stock Titan | Guardant Health (GH) CTO nets new shares after RSU vesting and tax withholding - Stock Titan |
| 2026-04-02 | -2.2% | news | Stock Titan | Guardant Health (NASDAQ: GH) CLO converts RSUs, withholds shares for taxes - Stock Titan |
| 2026-04-02 | -2.2% | news | Stock Titan | Guardant Health (GH) CPO gains stock from RSU vesting and tax withholding - Stock Titan |
| 2026-04-02 | -2.2% | news | Stock Titan | Guardant Health (NASDAQ: GH) CIO adds shares after RSU vesting - Stock Titan |
| 2026-04-02 | -2.2% | news | Stock Titan | 11,213 Guardant Health (GH) RSUs vest; 4,750 shares withheld for tax - Stock Titan |
| 2026-04-02 | -2.2% | executive | Stock Titan | Guardant Health (GH) co-CEO reports RSU vesting, tax-share withholdings and over 2.1M shares held - Stock Titan |
| 2026-04-02 | -2.2% | executive | Stock Titan | Guardant Health (GH) Co-CEO Talasaz converts RSUs, withholds shares for taxes - Stock Titan |
| 2025-10-20 | +2.1% | news | Investor's Business Daily | Stock Of The Day: Why IBD 50's Guardant Health Has Rallied 31% In A Month - Investor's Business Daily |
| 2025-10-20 | +2.1% | news | Investing.com | Guardant Health (GH) director Tariq Musa sells $7766 in stock - Investing.com |
| 2025-04-30 | -2.1% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2026-03-31 | +2.1% | expansion | Insider Monkey | Guardant Health (GH) and Verana Health Announces New Partnership |
| 2026-03-31 | +2.1% | news | Yahoo Finance | Why Is Guardant Health (GH) Stock Soaring Today - Yahoo Finance |
| 2026-03-31 | +2.1% | expansion | Yahoo Finance | Guardant Health (GH) and Verana Health Announces New Partnership - Yahoo Finance |
| 2023-11-03 | +2.0% | legal | SEC EDGAR | GH 8-K: 5.02 (SEC Filing) |
| 2026-03-18 | +2.0% | news | Yahoo Finance | Why Guardant Health’s (GH) 2026 Screening Story Reinforced Piper Sandler’s Bullish View - Yahoo Finance |
| 2026-03-18 | +2.0% | news | StockStory | 3 Reasons to Avoid GH and 1 Stock to Buy Instead - StockStory |
| 2026-03-18 | +2.0% | news | Stock Titan | Guardant Health (NASDAQ: GH) Form 144 shows proposed insider sale of shares - Stock Titan |
| 2026-03-18 | +2.0% | news | Stock Titan | Director at Guardant Health (GH) receives 232 shares via RSUs - Stock Titan |
| 2026-02-16 | +2.0% | news | DirectorsTalk Interviews | Guardant Health, Inc. (GH) Stock Analysis: Riding the 19.45% Potential Upside in Precision Oncology - DirectorsTalk Interviews |
| 2024-03-22 | -2.0% | legal | SEC EDGAR | GH 8-K: 5.02 and (SEC Filing) |
| 2022-02-28 | +2.0% | legal | SEC EDGAR | GH 8-K: 5.02 and 8.01 (SEC Filing) |
| 2023-05-08 | +1.8% | legal | SEC EDGAR | GH 8-K: 5.02 and (SEC Filing) |
| 2022-08-04 | +1.8% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2026-04-15 | -1.8% | earnings | MarketBeat | Sumitomo Mitsui Trust Group Inc. Sells 113,649 Shares of Guardant Health, Inc. $GH - MarketBeat |
| 2026-03-01 | -1.8% | M&A | Yahoo Finance | Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition - Yahoo Finance |
| 2026-02-17 | +1.8% | earnings | TradingView | Earnings To Watch: Guardant Health (GH) Reports Q4 Results Tomorrow - TradingView |
| 2026-02-17 | +1.8% | earnings | StockStory | Earnings To Watch: Guardant Health (GH) Reports Q4 Results Tomorrow - StockStory |
| 2025-01-13 | +1.8% | legal | SEC EDGAR | GH 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-28 | +1.7% | earnings | Seeking Alpha | Guardant Health Q3 2025 Earnings Preview |
| 2022-06-13 | +1.7% | legal | SEC EDGAR | GH 8-K: 1.02, 8.01 (SEC Filing) |
| 2025-12-22 | +1.7% | news | Seeking Alpha | Guardant Health is the top performing healthcare services stock YTD |
| 2026-01-13 | +1.6% | news | Seeking Alpha | 44th Annual J.P. Morgan Healthcare Conference |
| 2026-01-13 | +1.6% | news | Seeking Alpha | Guardant Health, Inc. (GH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2025-12-08 | +1.6% | news | Investing.com | Guardant Health (GH) director Clark sells $3.07 million in stock - Investing.com |
| 2025-09-24 | +1.5% | news | Seeking Alpha | Guardant Health, Inc. (GH) 2025 Investor Day Presentation |
| 2025-09-24 | +1.5% | news | Seeking Alpha | Guardant Health, Inc. (GH) 2025 Investor Day Call (Transcript) |
| 2026-01-22 | -1.4% | news | Seeking Alpha | Guardant nabs approval for Guardant360 companion diagnostic for Braftovi |
| 2026-03-17 | +1.2% | news | Yahoo Finance | Here’s Why Artisan Small Cap Fund Bets on Guardant Health (GH) - Yahoo Finance |
| 2024-05-31 | -1.2% | legal | SEC EDGAR | GH 8-K: 5.02 (SEC Filing) |
| 2025-11-05 | -1.2% | news | Investing.com | Guardant Health stock falls after pricing upsized convertible notes offering - Investing.com |
| 2025-11-05 | -1.2% | news | TradingView | Why Guardant Health (GH) Shares Are Sliding Today - TradingView |
| 2024-02-01 | -1.2% | legal | SEC EDGAR | GH 8-K: 5.02 (SEC Filing) |
| 2026-04-23 | -1.1% | analyst | The Globe and Mail | Analysts Are Bullish on These Healthcare Stocks: Guardant Health (GH), Crescent Biopharma (CBIO) - The Globe and Mail |
| 2026-04-23 | -1.1% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | Guardant Health Inc. posts 38.6% negative EPS miss vs estimates - Community Volume Signals - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-06 | -1.1% | news | StockStory | Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know |
| 2026-04-06 | -1.1% | news | Seeking Alpha | Guardant Health: Leveraging Liquid Biopsy Testing Momentum |
| 2026-04-06 | -1.1% | news | Seeking Alpha | Guardant Health: Leveraging Liquid Biopsy Testing Momentum (NASDAQ:GH) - Seeking Alpha |
| 2026-04-06 | -1.1% | legal | Stock Titan | [144] Guardant Health, Inc. SEC Filing - Stock Titan |
| 2026-04-06 | -1.1% | earnings | MarketBeat | SG Americas Securities LLC Invests $1.74 Million in Guardant Health, Inc. $GH - MarketBeat |
| 2026-04-06 | -1.1% | earnings | MarketBeat | Guardant Health, Inc. $GH is Capricorn Fund Managers Ltd's 6th Largest Position - MarketBeat |
| 2026-02-12 | -1.1% | earnings | Yahoo Finance | Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance |
| 2026-02-12 | -1.1% | news | Stock Titan | Community groups offered up to 100 free colon cancer blood tests for March events - Stock Titan |
| 2026-01-26 | -1.0% | earnings | Seeking Alpha | Guardant Health: Look For Explosive Revenue Growth Ahead |
| 2026-01-26 | -1.0% | earnings | Seeking Alpha | Guardant Health: Look For Explosive Revenue Growth Ahead (NASDAQ:GH) - Seeking Alpha |
| 2026-04-19 | +1.0% | news | simplywall.st | Is It Too Late To Consider Guardant Health (GH) After Its 100% One Year Surge? - simplywall.st |
| 2026-04-07 | +1.0% | analyst | Investing.com | Canaccord reiterates Guardant Health stock rating on cancer test growth - Investing.com |
| 2026-04-07 | +1.0% | executive | Stock Titan | Guardant Health (GH) Chief People Officer sells 3,832 shares in open market - Stock Titan |
| 2026-04-07 | +1.0% | executive | Investing.com | Guardant Health (GH) chief people officer sells $355k in stock - Investing.com |
| 2026-04-20 | +0.9% | news | Stock Titan | Guardant Health director exercises 232 RSUs into shares | GH Insider Trading - Stock Titan |
| 2026-04-01 | +0.7% | news | Zacks | What's Fueling TEM Diagnostics Segment's Strong 2026 Outlook? |
| 2026-04-01 | +0.7% | news | StockStory | Why Is Guardant Health (GH) Stock Soaring Today |
| 2026-04-01 | +0.7% | M&A | Stock Titan | Director at Guardant Health (GH) acquires 155 shares via RSUs - Stock Titan |
| 2021-08-05 | -0.6% | legal | SEC EDGAR | GH 8-K: 5.02 and (SEC Filing) |
| 2021-08-05 | -0.6% | legal | SEC EDGAR | GH 8-K: 2.02 and (SEC Filing) |
| 2025-09-15 | +0.5% | legal | SEC EDGAR | GH 8-K: 5.02 and (SEC Filing) |
| 2026-03-19 | -0.5% | news | Yahoo Finance | 3 Reasons to Avoid GH and 1 Stock to Buy Instead - Yahoo Finance |
| 2026-02-26 | -0.4% | news | Yahoo Finance | Guardant Health (GH) Gained from Better-Than-Expected Results - Yahoo Finance |
| 2025-09-30 | +0.3% | news | Yahoo Finance | Guardant Health, Inc. (GH) Unveils Shield V2, Boosts Early Cancer Detection Accuracy - Yahoo Finance |
| 2025-11-08 | -0.3% | news | Yahoo Finance | Guardant Health (GH): Assessing Valuation Following Expanded Equity and Convertible Capital Raises - Yahoo Finance |
| 2025-12-11 | +0.3% | news | simplywall.st | Have Guardant Health Insiders Been Selling Stock? - simplywall.st |
| 2024-01-08 | -0.3% | legal | SEC EDGAR | GH 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-10-24 | +0.3% | legal | SEC EDGAR | GH 8-K: 5.02 and (SEC Filing) |
| 2026-03-02 | +0.2% | analyst | DirectorsTalk Interviews | Guardant Health, Inc. (GH) Stock Analysis: A 41% Upside Potential With Strong Buy Ratings - DirectorsTalk Interviews |
| 2026-03-02 | +0.2% | M&A | Stock Titan | Guardant Health (GH) director acquires 154 shares via RSU vesting - Stock Titan |
| 2026-03-27 | -0.1% | news | Yahoo Finance | Why Guardant Health (GH) Stock Is Falling Today - Yahoo Finance |
| 2026-03-05 | -0.1% | news | Yahoo Finance | BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now? - Yahoo Finance |
| 2025-11-07 | +0.1% | legal | SEC EDGAR | GH 8-K: 1.01, 2.03, 3.02, 8.01 (SEC Filing) |
| 2026-04-24 | — | earnings | MarketBeat | Universal Beteiligungs und Servicegesellschaft mbH Has $29.21 Million Stock Position in Guardant Health, Inc. $GH - MarketBeat |